U.S. Office REITs Stock News

NasdaqGM:SGMT
NasdaqGM:SGMTBiotechs

Why Sagimet Biosciences (SGMT) Is Up 7.7% After Denifanstat’s Phase 3 Acne Success And What's Next

Sagimet Biosciences recently reported that Ascletis Pharma’s Phase 3 trial of ASC40 (Denifanstat) for acne met all primary and secondary endpoints and was well-tolerated, with no serious adverse events observed. The results highlight fatty acid synthase (FASN) inhibition as a potentially new way to treat acne, with findings slated for presentation at upcoming medical congresses and in scientific publications. Next, we’ll examine how Denifanstat’s Phase 3 success in acne may influence Sagimet...
NasdaqGS:UVSP
NasdaqGS:UVSPBanks

Exploring 3 Undervalued Small Caps With Insider Buying Activity

As February begins, U.S. stock markets have shown a strong start with major indices like the Dow Jones and S&P 500 climbing significantly, reflecting positive sentiment despite broader economic uncertainties such as delayed job reports due to a government shutdown. In this environment of fluctuating market dynamics, small-cap stocks often present unique opportunities for investors looking for potential growth, particularly when insider buying activity suggests confidence from those closest to...
NasdaqGS:COCO
NasdaqGS:COCOBeverage

Discover 3 Stocks Possibly Trading At Discounts Of Up To 49.6%

As February begins, the U.S. stock market has shown significant upward momentum, with major indexes such as the Dow Jones and S&P 500 experiencing notable gains. In this environment of rising indices and economic developments, identifying undervalued stocks can be a strategic move for investors looking to capitalize on potential discounts in the market.